Literatur
-
1
Grines C L, Serruys P, O’Neill W W.
Fibrinolytic therapy: Is it a treatment of the past?.
Circ.
2003;
107
2538-2542
-
2
Hamm C W, Arntz H R, Bode C. et al .
Leitlinien Akutes Koronarsyndrom Teil 2: Akutes Koronarsyndrom mit ST-Hebung.
Z Kardiol.
2004;
93
324-341
-
3 Mannebach H, Horstkotte D. Akuter Myokardinfarkt: Interventionelle Therapieoptionen. Steinkopf Verlag In Arntz HR, Schuster HP (Herausgeber) Die Notfalltherapie bei akutem Myokardinfarkt 2000: 79-91
-
4
Montalescot G, Barragan P, Wittenberg O. et al. for the ADMIRAL investigators .
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
N Engl J Med.
2002;
344
1895-1903
-
5
Schömig A, Kastrati A, Dirschinger J. et al .
Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.
N Engl J Med.
2000;
343
385-391
-
6
Schühlen H, Mehili J, Neverve J. et al .
Tickt die Uhr genauso gegen die Katheterintervention wie gegen die Thrombolyse?.
Z Kardiol.
2003;
92
(Suppl 1)
165
-
7
Schneider H, Weber F, Paranskaja L. et al .
Leitlinienkonforme interventionelle Therapie des akuten ST-Hebungsinfarktes in ländlichen Regionen durch Netzwerkbildung.
Dtsch Med Wochenschr.
2004;
129
2162-2166
-
8
Van de Werf F, Ardissino D, Betriu A. et al .
Management of acute myocardial infarction in patients presenting with ST-segment elevation. Task Force of the ESC.
Eur Heart J.
2003;
24
28-66
-
9
Verheugt F W.
GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction (Review).
Thromb Res.
2001;
103
(Suppl 1)
113-116
-
10
Zahn R, Schiele R, Schneider S. et al .
Clinical practice of primary angioplasty for the treatment of acute myocardial infarction in Germany: results from the MITRA and MIR registries.
Z Kardiol.
2002;
91
(Suppl 3)
64-71
-
11
Zahn R, Schiele R, Hauptmann K E. et al .
Long pre-hospital delays are associated with increasing mortality in patients with acute myocardial infarction treated with intravenous thrombolysis but not in patients treadet with primary angioplasty (abstract).
Circulation.
1999;
100
(Suppl I)
358
-
12
Zorman S, Zorman D, Noc M.
Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty.
Am J Cardiol.
2002;
90
533-536
Dr. H. Schneider
PD Dr. F. Weber
Prof. Dr. C. A. Nienaber
Abteilung Kardiologie, Klinik und Poliklinik für Innere Medizin der Universität Rostock
Postfach 100888
18055 Rostock
